Concizumab + Coagulation Factor Viia Recombinant Human Interaction
Majorinteraction on record
Description
High and/or frequent doses increase risk of thromboembolism. Additive and synergistic increase in thrombin peak observed with concomitant use.
Mechanism
Additive and synergistic increase in thrombin generation
Source: NLP:concizumab